• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-17

  Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that markedly improves detection of TOR/mTOR pathway inhibitors. The system distinguishes TOR1-dependent growth inhibition at substantially lower concentrations than wild-type yeast and provides a practical early-stage screen for geroscience and oncology programs.

• Methylprednisolone Sodium Succinate Lab Workflows

  2026-08-16

  Build more informative inflammation, leukocyte, and tumor-cell assays with a water-compatible synthetic corticosteroid and concentration-aware controls. This guide turns Methylprednisolone Sodium Succinate into a reproducible workflow for cytokine profiling, ROS testing, chemotaxis, apoptosis, and translational injury-model research.

• Nurr1 Neurogenesis in the Rat Claustrum

  2026-08-15

  Fang, Wang, and Naumann mapped the developmental emergence and birth timing of Nurr1-positive neurons across the rat claustrum and adjacent lateral cortex. Their combination of developmental Nurr1 expression profiling with EdU birth dating reveals sequential neurogenesis and regional gradients that refine interpretation of claustrum boundaries and ontogeny.

• Ceapin-A7 for Reproducible ER Stress Assays

  2026-08-14

  This scenario-driven guide shows how Ceapin-A7 (SKU BA3709) can help researchers isolate ATF6α signaling when interpreting viability, proliferation, and cytotoxicity data. It covers controls, dosing, storage, assay compatibility, and limitations when connecting ATF6α inhibition with PERK–JAK1–STAT3 biology.

• EIF4A3–circEIF2S2 in Colorectal Cancer

  2026-08-14

  The reference study identifies an EIF4A3–circEIF2S2–miR-646–UHMK1 regulatory axis that links circular RNA biogenesis to colorectal cancer growth, metastasis, and immune suppression. Its combined molecular, cellular, co-culture, and xenograft evidence positions circEIF2S2 as a mechanistically informed biomarker candidate, while also highlighting the need for further validation in clinically representative models.

• Sodium Oxamate: A Causal Lactylation Workflow

  2026-08-13

  Sodium Oxamate is more than an LDH-A inhibitor: it can help researchers test whether lactate-linked chromatin changes are causally connected to tumor behavior. This guide translates TNBC lactylation findings into a rigorous, interpretable cancer metabolism research workflow.

• Nurr1 Gradients in the Developing Rat Claustrum

  2026-08-13

  Fang, Wang, and Naumann mapped the emergence and birth timing of Nurr1-positive neurons across the rat claustrum and adjacent lateral cortex. By combining developmental Nurr1 expression profiling with EdU birth dating, the study resolved sequential neurogenesis and spatial gradients that refine how claustral subregions are defined.

• EGTA: Turning Calcium Signals Into Causal Insight

  2026-08-12

  EGTA, also known as egtazic acid, is more than a calcium chelator: it is a strategic perturbation tool for distinguishing calcium-dependent signaling from downstream cellular injury. This thought-leadership guide connects cardiac vagal neuron electrophysiology with translational workflows in neuroprotection, apoptosis assays, and inflammation research while defining practical limits for interpretation.

• EdU Imaging Kits (488) for CRC Proliferation

  2026-08-12

  Use EdU Imaging Kits (488) to connect colorectal cancer pathway perturbations with direct S-phase DNA synthesis measurements in microscopy or flow cytometry workflows. This guide translates circEIF2S2 research into practical assay design, controls, optimization steps, and troubleshooting without confusing DNA synthesis with total cell growth.

• Cy3 Goat Anti-Human IgG (H+L) Antibody: Bench Guide

  2026-08-11

  This scenario-based guide explains how Cy3 Goat Anti-Human IgG (H+L) Antibody, SKU K1208, can strengthen human IgG detection alongside viability, proliferation, and cytotoxicity workflows. It covers spectral compatibility, controls, storage, optimization, interpretation, and practical vendor-selection criteria.

• Mitomycin C: Mechanism and Cancer Research Guide

  2026-08-11

  Mitomycin C is an antitumor antibiotic that forms covalent DNA adducts and inhibits DNA replication. Its documented activity includes TRAIL sensitization in p53-deficient colon cancer models, making it useful for apoptosis signaling research and cancer biology workflows.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-10

  Breen and colleagues developed a drug-sensitized Saccharomyces cerevisiae platform that detects TOR/mTOR inhibitors at substantially lower concentrations than a wild-type yeast assay. The study validates the system with Torin1, omipalisib, AZD8055, and aminophylline, while showing no evidence of TOR inhibition for several tested compounds, including nebivolol.

• Lopinavir: From HIV Potency to MERS Assays

  2026-08-09

  Lopinavir and ABT-378 offer a useful model for connecting molecular HIV protease inhibition with cell-based antiviral screening. This article explains how to interpret potency, resistance, serum effects, and the MERS-CoV repurposing evidence without overstating cross-pathogen conclusions.

• DNase I (RNase-free) for Clean RNA Workflows

  2026-08-08

  Build cleaner RNA extraction, RT-PCR, and in vitro transcription workflows with targeted DNA digestion and RNase-conscious handling. The same enzyme also supports carefully titrated chromatin and RNA:DNA hybrid studies, provided metal-ion chemistry and downstream cleanup are controlled.

• Epmedin C Targets DON Immunotoxicity in Chicken Macrophages

  2026-08-07

  The reference study connects low-dose deoxynivalenol exposure with caspase-1/IL-1β activation, elevated reactive oxygen species, and impaired immune function in chickens. By combining network pharmacology, molecular docking, macrophage assays, coculture experiments, and chick validation, it identifies epmedin C as a candidate intervention for DON-associated immunotoxicity.

16453 records 1/1097 page Next 12345 下5页 Last page